Intravitreous Pegaptanib Could Halt Vision Loss

Monday, April 20, 2009

Comments

medpageToday

Intravitreous injections of pegaptanib (Macugen) may help prevent further vision loss from central retinal vein occlusion, but does little to reverse it, researchers found.

Full Story

Retina Products and Equipment »

Which of the following are NOT associated with an increased risk of developing proliferative diabetic retinopathy?
1. Intraretinal hemorrhages in 4 quadrants.
2. Nerve fiber layer infarcts in 2 or more quadrants.
3. Venous beading.
4. Intraretinal microvascular abnormalities.
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Intravitreous Pegaptanib Could Halt Vision Loss

Comments

Related Categories

Retina Products and Equipment »

Quick Quiz

Which of the following are NOT associated with an increased risk of developing proliferative diabetic retinopathy?

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

OPMI LUMERA 700 Surgical Microscope

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us